跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“SYCAMORE”
全部
11
临床试验
0
药物
4
机构
0
资讯
7
去年
Sycamore Partners Completes $11.45 Per Share Acquisition of Walgreens Boots Alliance
2年前
Recursion's AI-Derived Drug REC-994 Shows Promise in Phase 2 Trial for Cerebral Cavernous Malformation
2年前
AI-Driven Drug Discovery Shows Promise and Challenges in Cerebral Cavernous Malformation Trial
去年
Evernorth Health Services Makes $3.5 Billion Investment in Shields Health Solutions to Expand Specialty Pharmacy Network
去年
Recursion's REC-994 Shows Promising Safety and Efficacy Signals in Phase 2 CCM Trial
2年前
Recursion Anticipates Phase 2 Data Readouts and Advances Platform Capabilities
去年
Phase III Clinical Trials Reveal Advances in Non-Infectious Uveitis Treatment Options